Contrave

You’ve already tried diets — that’s common. There are safe, effective alternatives and combinations beyond “just a diet.” Below I’ll summarize practical options, what to expect from each, pros/cons (including brand names), and the next best steps. Quick reality check A safe steady rate is about 1–2 lb/week. Losing 30 lb typically takes a few months to a year depending on the approach. Most people do best with a combination of medical care, behavior change, and activity — not only willpower. Main options 1) Structured lifestyle + behavioral support (first-line, often needed with any medical treatment) What: individualized calorie plan, habit change, regular physical activity, sleep and stress management, and therapy for emotional or binge eating (CBT). Who helps: Registered dietitian (RDN), behavioral therapist or psychologist, exercise physiologist. Programs/brands: WW (WeightWatchers) — group support and coaching; Noom — app-based behavior-change coaching; MyFitnessPal or Lose It! — for tracking. Expected effect: 5–10% body-weight loss for many people when done intensively and sustained. Pros: low risk, addresses root habits. Cons: requires time and ongoing support; alone may be insufficient for larger losses. 2) Prescription medications (for long-term medical management) What: medications that reduce appetite/increase satiety or alter absorption. Often used with lifestyle therapy. Brands to know: Wegovy (semaglutide 2.4 mg) — GLP‑1 approved for chronic weight management. Zepbound (tirzepatide) — approved for weight management (and tirzepatide as Mounjaro for diabetes has led to large weight loss). Contrave (naltrexone + bupropion), Qsymia (phentermine/topiramate), Xenical (orlistat) / Alli (OTC orlistat). Plenity — a prescription oral hydrogel that increases fullness (for BMI 25–40). Expected effect: varies by drug — many newer GLP‑1/Tirzepatide therapies commonly produce double-digit percent weight loss (often 10–20% or more in trials); older drugs smaller effects. Pros: can produce large, sustained weight loss when continued. Cons: side effects (nausea, GI symptoms, rare serious risks), cost/insurance barriers, need medical supervision, some contraindications (e.g., Wegovy has thyroid C-cell tumor warning; discuss with your provider). 3) Device or endoscopic options (less invasive than surgery) What: gastric balloon (temporary), endoscopic sleeve procedures. Brands/programs: Orbera, ReShape (balloons), also newer endoscopic sleeve gastroplasty at specialized centers. Expected effect: moderate weight loss while device is in place; often used as bridge or for people who are not surgical candidates. Pros: less invasive than surgery. Cons: temporary, side effects, requires specialist. 4) Bariatric surgery (most effective option for large sustained weight loss and for improving diabetes/hypertension) What: surgical procedures that reduce stomach size and/or alter absorption: sleeve gastrectomy, Roux-en-Y gastric bypass, biliopancreatic diversion with duodenal switch (less common). Where: accredited bariatric surgery programs/Centers of Excellence (e.g., Mayo Clinic, Cleveland Clinic, many university hospitals). Expected effect: substantial and durable weight loss (often the largest percent losses of all options) and major improvements in obesity-related conditions. Pros: greatest long-term weight loss and health benefit for many. Cons: surgical risks, need lifelong follow-up and nutrition monitoring, possible nutrient deficiencies. Typical candidate: commonly considered if BMI ≥40, or BMI ≥35 with obesity-related comorbidities (diabetes, sleep apnea, etc.). Some candidates with lower BMI and severe diabetes may also qualify — discuss with a surgeon/endocrinologist. 5) Multidisciplinary weight-management programs / telemedicine metabolic programs What: medical supervision + coaching + meds + remote monitoring. Brands/services: Calibrate (telemedicine metabolic program combining GLP‑1 medication with coaching), medical weight-loss clinics affiliated with hospitals, or local obesity medicine specialists. Pros: combines medical, nutrition and behavioral supports in one program. Cons: cost and insurance coverage vary. Other important steps and considerations Medical evaluation: see your PCP to check thyroid, diabetes, medications that cause weight gain (some antidepressants, insulin, beta blockers), and screen for sleep apnea. That guides safe treatment choices. Mental-health screening: assess for binge eating disorder or emotional eating; treating these improves success. Insurance and cost: many weight-loss meds and procedures require prior authorization; Wegovy and Zepbound can be expensive without coverage. Ask your provider about patient-assistance programs. Safety: don’t start prescription drugs or weight-loss surgery without medical evaluation. Some meds have specific contraindications/boxed warnings. How effective are these for a 30-lb goal? If your starting weight is moderate, intensive lifestyle alone might get you part of the way (5–10% body weight). For many people a 30-lb loss is easier to achieve and maintain with prescription medication or surgery in addition to behavior change. Combining approaches is common. Suggested next steps (practical) Book an appointment with your primary care provider for a full evaluation (BMI, labs, med review, sleep/mental-health screening). Ask for a referral to a registered dietitian experienced in medical weight management and to an obesity medicine specialist (ABOM-certified) or endocrinologist if appropriate. If interested in medications, ask whether you’re a candidate for GLP‑1 therapy (Wegovy, Zepbound) or others and discuss cost/coverage. If your BMI and health profile suggest it, ask whether a bariatric surgery consult is appropriate. If you want, I can: calculate your BMI if you give height/weight, draft questions to ask your doctor, or help you find local clinics or programs. Would you like me to calculate your BMI and show a tailored next-step plan (medications vs. surgery vs. lifestyle) based on your height, weight, medical history, and preferences?

Mentioned in position 5 of 11

Short answer: Many people regain some — often most — of the weight they lost after stopping a GLP‑1. That’s because the drugs change appetite, hunger signals, and sometimes energy use; when the drug is stopped those biological drivers tend to come back unless you’ve permanently changed behaviors or continue some other therapy. What happens physiologically GLP‑1 receptor agonists (e.g., semaglutide, tirzepatide, liraglutide) reduce appetite, slow gastric emptying, and change reward/hunger signaling. When the drug is stopped appetite typically increases, food cravings return, and calorie intake often goes up. Energy expenditure can also shift toward weight regain. There is no classic “withdrawal” syndrome, but you can experience a strong rebound in hunger and rapid weight regain if you don’t have a maintenance plan. Typical clinical experience and evidence Clinical trials and real‑world experience show substantial weight regain after stopping treatment unless people maintain intensive lifestyle changes or remain on some therapy. How much you regain varies by person, how long you were on therapy, and what habits/support you put in place for maintenance. Risks to watch for If you have diabetes, stopping a GLP‑1 can raise blood glucose and A1c — monitor with your clinician. If you’re pregnant or planning pregnancy, GLP‑1s should be stopped and discussed with your provider. Practical steps to reduce regain Plan ahead with your prescriber: a) discuss whether long‑term therapy is appropriate, b) discuss tapering or switching strategies if needed. Strengthen lifestyle supports before and after stopping: consistent higher‑protein diet, regular resistance and aerobic exercise, sleep and stress management, and regular self‑monitoring (weight, food). Get multidisciplinary support: a registered dietitian, behavioral therapy or cognitive‑behavioral strategies, and an obesity medicine specialist often improve long‑term maintenance. Consider alternative or adjunctive treatments used for maintenance (discuss with your clinician): metformin, naltrexone/bupropion (Contrave), or continued lower‑dose GLP‑1 therapy if appropriate. Frequent follow‑up and early action if weight begins to climb back. Brands and services to discuss with your clinician (examples) GLP‑1s: Wegovy (semaglutide) and Saxenda (liraglutide) are FDA‑approved for weight management; Ozempic (semaglutide) and Mounjaro (tirzepatide) are diabetes drugs that are sometimes used in weight management; Zepbound (tirzepatide) is another weight‑management option. These are effective for weight loss but stopping them commonly leads to weight regain. If you stop a GLP‑1 and need ongoing help: Contrave (naltrexone/bupropion) or metformin are sometimes used as alternatives or adjuncts (discuss with your clinician). Support services: work with an obesity medicine specialist (find through the Obesity Medicine Association or American Board of Obesity Medicine), a registered dietitian (Academy of Nutrition and Dietetics), or structured programs like a local multidisciplinary weight‑management clinic, commercial programs (e.g., WW), or digital behavioral programs (e.g., Noom) — pick one you can stick with long term. Bottom line Expect some risk of weight regain after stopping GLP‑1 therapy. To minimize regain, plan the stop with your clinician, strengthen lifestyle and behavioral supports, consider maintenance medication if appropriate, and keep regular follow‑up and monitoring. If you want, tell me: which GLP‑1 you’re taking (brand/dose) and why you’re thinking of stopping, and I can give a more tailored plan you can discuss with your provider.

Mentioned in position 1 of 3